Literature DB >> 25306394

TNF-α promotes invasive growth through the MET signaling pathway.

Viola Bigatto1, Francesca De Bacco1, Elena Casanova1, Gigliola Reato2, Letizia Lanzetti2, Claudio Isella2, Ivana Sarotto1, Paolo M Comoglio3, Carla Boccaccio4.   

Abstract

The inflammatory cytokine Tumor Necrosis Factor Alpha (TNF-α) is known to trigger invasive growth, a physiological property for tissue healing, turning into a hallmark of progression in cancer. However, the invasive response to TNF-α relies on poorly understood molecular mechanisms. We thus investigated whether it involves the MET oncogene, which regulates the invasive growth program by encoding the tyrosine kinase receptor for Hepatocyte Growth Factor (HGF). Here we show that the TNF-α pro-invasive activity requires MET function, as it is fully inhibited by MET-specific inhibitors (small-molecules, antibodies, and siRNAs). Mechanistically, we show that TNF-α induces MET transcription via NF-κB, and exploits MET to sustain MEK/ERK activation and Snail accumulation, leading to E-cadherin downregulation. We then show that TNF-α not only induces MET expression in cancer cells, but also HGF secretion by fibroblasts. Consistently, we found that, in human colorectal cancer tissues, high levels of TNF-α correlates with increased expression of both MET and HGF. These findings suggest that TNF-α fosters a HGF/MET pro-invasive paracrine loop in tumors. Targeting this ligand/receptor pair would contribute to prevent cancer progression associated with inflammation.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HGF; Inflammation; Invasion; MET; MET inhibitor; TNF-α

Mesh:

Substances:

Year:  2014        PMID: 25306394      PMCID: PMC5528655          DOI: 10.1016/j.molonc.2014.09.002

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  46 in total

Review 1.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

2.  Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.

Authors:  Francesca De Bacco; Paolo Luraghi; Enzo Medico; Gigliola Reato; Flavia Girolami; Timothy Perera; Pietro Gabriele; Paolo M Comoglio; Carla Boccaccio
Journal:  J Natl Cancer Inst       Date:  2011-04-04       Impact factor: 13.506

Review 3.  Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Authors:  Tim Bongartz; Alex J Sutton; Michael J Sweeting; Iain Buchan; Eric L Matteson; Victor Montori
Journal:  JAMA       Date:  2006-05-17       Impact factor: 56.272

4.  Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK.

Authors:  Rudolf Waelchli; Birgit Bollbuck; Christian Bruns; Thomas Buhl; Jörg Eder; Roland Feifel; Rene Hersperger; Philipp Janser; Laszlo Revesz; Hans-Günter Zerwes; Achim Schlapbach
Journal:  Bioorg Med Chem Lett       Date:  2005-10-19       Impact factor: 2.823

5.  Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene.

Authors:  Selma Pennacchietti; Paolo Michieli; Maria Galluzzo; Massimiliano Mazzone; Silvia Giordano; Paolo M Comoglio
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

6.  Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

Authors:  Boryana K Popivanova; Kazuya Kitamura; Yu Wu; Toshikazu Kondo; Takashi Kagaya; Shiuchi Kaneko; Masanobu Oshima; Chifumi Fujii; Naofumi Mukaida
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

Review 7.  Tumour necrosis factor and cancer.

Authors:  Frances Balkwill
Journal:  Nat Rev Cancer       Date:  2009-04-03       Impact factor: 60.716

8.  Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion.

Authors:  Yadi Wu; Jiong Deng; Piotr G Rychahou; Suimin Qiu; B Mark Evers; Binhua P Zhou
Journal:  Cancer Cell       Date:  2009-05-05       Impact factor: 31.743

9.  Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor.

Authors:  L Naldini; L Tamagnone; E Vigna; M Sachs; G Hartmann; W Birchmeier; Y Daikuhara; H Tsubouchi; F Blasi; P M Comoglio
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

10.  Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.

Authors:  Laetitia Marisa; Aurélien de Reyniès; Alex Duval; Janick Selves; Marie Pierre Gaub; Laure Vescovo; Marie-Christine Etienne-Grimaldi; Renaud Schiappa; Dominique Guenot; Mira Ayadi; Sylvain Kirzin; Maurice Chazal; Jean-François Fléjou; Daniel Benchimol; Anne Berger; Arnaud Lagarde; Erwan Pencreach; Françoise Piard; Dominique Elias; Yann Parc; Sylviane Olschwang; Gérard Milano; Pierre Laurent-Puig; Valérie Boige
Journal:  PLoS Med       Date:  2013-05-21       Impact factor: 11.069

View more
  23 in total

1.  Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer.

Authors:  Jia Wu; Bailiang Li; Xiaoli Sun; Guohong Cao; Daniel L Rubin; Sandy Napel; Debra M Ikeda; Allison W Kurian; Ruijiang Li
Journal:  Radiology       Date:  2017-07-14       Impact factor: 11.105

2.  Effect of expressions of tumor necrosis factor α and interleukin 1B on peritoneal metastasis of gastric cancer.

Authors:  Lin Guo; Jin-Lei Ou; Tong Zhang; Liang Ma; Long-Fei Qu
Journal:  Tumour Biol       Date:  2015-06-12

3.  Combined c-Met/Trk Inhibition Overcomes Resistance to CDK4/6 Inhibitors in Glioblastoma.

Authors:  Inan Olmez; Ying Zhang; Laryssa Manigat; Mouadh Benamar; Breanna Brenneman; Ichiro Nakano; Jakub Godlewski; Agnieszka Bronisz; Jeongwu Lee; Tarek Abbas; Roger Abounader; Benjamin Purow
Journal:  Cancer Res       Date:  2018-05-29       Impact factor: 12.701

4.  Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.

Authors:  Roselyne Y Wagner; Flavie Luciani; Muriel Cario-André; Alain Rubod; Valérie Petit; Laila Benzekri; Khaled Ezzedine; Sébastien Lepreux; Eirikur Steingrimsson; A Taieb; Yvon Gauthier; Lionel Larue; Véronique Delmas
Journal:  J Invest Dermatol       Date:  2015-01-29       Impact factor: 8.551

Review 5.  Comprehensive review of targeted therapy for colorectal cancer.

Authors:  Yuan-Hong Xie; Ying-Xuan Chen; Jing-Yuan Fang
Journal:  Signal Transduct Target Ther       Date:  2020-03-20

6.  High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab.

Authors:  S S Kumar; Y Tomita; J Wrin; M Bruhn; A Swalling; M Mohammed; T J Price; J E Hardingham
Journal:  Clin Transl Oncol       Date:  2016-12-22       Impact factor: 3.405

7.  Utility of Hepatocyte Growth Factor as a Biomarker for Early Diagnosis of Pulmonary Artery Hypertension.

Authors:  Mingting Liang; Ying Pang; Shuguang Zhang; Mei Zhang
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

8.  Normal human thyroid cells, BCPAP, and TPC-1 thyroid tumor cell lines display different profile in both basal and TNF-α-induced CXCL8 secretion.

Authors:  Francesca Coperchini; Patrizia Pignatti; Paola Leporati; Andrea Carbone; Laura Croce; Flavia Magri; Luca Chiovato; Mario Rotondi
Journal:  Endocrine       Date:  2015-10-08       Impact factor: 3.633

9.  TNF-α promotes invasive growth through the MET signaling pathway.

Authors:  Viola Bigatto; Francesca De Bacco; Elena Casanova; Gigliola Reato; Letizia Lanzetti; Claudio Isella; Ivana Sarotto; Paolo M Comoglio; Carla Boccaccio
Journal:  Mol Oncol       Date:  2014-09-26       Impact factor: 6.603

10.  Induction of oxidative stress by Taxol® vehicle Cremophor-EL triggers production of interleukin-8 by peripheral blood mononuclear cells through the mechanism not requiring de novo synthesis of mRNA.

Authors:  Anna N Ilinskaya; Jeffrey D Clogston; Scott E McNeil; Marina A Dobrovolskaia
Journal:  Nanomedicine       Date:  2015-08-15       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.